{"url_path":"/sec/kura/8-k/2026-06-04/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1422143/0001193125-26-257368-index.html","accession_number":"0001193125-26-257368","cik":"0001422143","ticker":"KURA","issuer_name":"Kura Oncology, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1422143/0001193125-26-257368-index.html","primary_entity_key":"0001422143","primary_entity_name":"Kura Oncology, Inc."},"word_count":381,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 4, 2026, we held our Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 6, 2026, the record date for the Annual Meeting, there were 88,762,704 shares of common stock outstanding, of which 69,778,580 shares of common stock were present virtually or represented by proxy at the Annual Meeting.\n\nAt the Annual Meeting, stockholders:\n\n(1) elected Diane Parks, Mary T. Szela and Michael J. Vasconcelles, M.D. as Class III directors to hold office until our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal;\n\n(2) ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;\n\n(3) approved, on an advisory basis, the compensation paid to our named executive officers (“Say-on-Pay”) as disclosed in the proxy statement;\n\n(4) indicated, on an advisory basis, the preferred frequency of holding future Say-on-Pay advisory votes on executive\ncompensation;\n\n(5) approved our Amended 2014 Plan; and\n\n(6) approved our Amended ESPP.\n\nThe following sets forth detailed information regarding the final results of the voting for the Annual Meeting (with any fractional share amounts rounded to the nearest whole number):\n\nProposal 1. Election of Directors\n\nName of Director Elected\n\nFor\n\nWithheld\n\nBroker Non-Votes\n\nDiane Parks\n\n44,060,724\n\n14,620,308\n\n11,097,548\n\nMary T. Szela\n\n38,859,502\n\n19,821,530\n\n11,097,548\n\nMichael J. Vasconcelles, M.D.\n\n \n\n58,169,894\n\n \n\n511,138\n\n \n\n11,097,548\n\nProposal 2. Ratification of the Appointment of Independent Registered Public Accounting Firm\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n69,385,497\n\n \n\n140,763\n\n \n\n252,320\n\n—\n\nProposal 3. Advisory Vote on Executive Compensation\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n48,783,834\n\n \n\n1,141,854\n\n \n\n8,755,344\n\n11,097,548\n\nProposal 4. Advisory Indication on Frequency of Stockholder Advisory Votes on Executive Compensation\n\n1 Year\n\n2 Years\n\n3 Years\n\nAbstain\n\n \n\nBroker Non-Votes\n\n48,362,762\n\n \n\n54,055\n\n \n\n1,586,672\n\n8,677,543\n\n \n\n11,097,548\n\n \n\n \n\n \n\nBased on these results and consistent with our recommendation, our Board of Directors has determined that we will conduct future stockholder advisory votes on the compensation of our named executive officers every year.\n\nProposal 5. Approval of our Amended 2014 Plan\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n48,402,820\n\n \n\n10,099,296\n\n \n\n178,916\n\n11,097,548\n\nProposal 6. Approval of our Amended ESPP\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n58,306,174\n\n \n\n213,434\n\n \n\n161,424\n\n11,097,548"}